RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/C2240A9AA1C72915FF9D3E9BED33DEAA6E9F30D665346B8F71EEF2C007FCB79D9C2E898702359ADAEF39D559E580E2B0http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C2240A9AA1C72915FF9D3E9BED33DEAA6E9F30D665346B8F71EEF2C007FCB79D9C2E898702359ADAEF39D559E580E2B0http://www.w3.org/2000/01/rdf-schema#comment"our results indicated that IL-1beta treatment resulted in a significant increase in expression of the transcriptional factor interferon regulatory factor-1 (IRF-1) at both the mRNA and protein levels which was significantly ameliorated by treatment with Nebivolol. The combination of these findings suggests that Nebivolol can potentially be applied in human osteoarthritis treatment"xsd:string
http://purl.uniprot.org/uniprot/#_FD1C2C5DA005FD96193B4DB1280A23D13726A38CA7C012BB8CBDEBF004CC19751FB856FC30FCBAE14A633629CE2F0E43http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/C2240A9AA1C72915FF9D3E9BED33DEAA6E9F30D665346B8F71EEF2C007FCB79D9C2E898702359ADAEF39D559E580E2B0
http://purl.uniprot.org/uniprot/O43645http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/C2240A9AA1C72915FF9D3E9BED33DEAA6E9F30D665346B8F71EEF2C007FCB79D9C2E898702359ADAEF39D559E580E2B0
http://purl.uniprot.org/uniprot/#_O43645-mappedCitation-28512729http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/C2240A9AA1C72915FF9D3E9BED33DEAA6E9F30D665346B8F71EEF2C007FCB79D9C2E898702359ADAEF39D559E580E2B0